MD Training, Specialty Affect Menopause Treatments

New research reveals that treatments for troublesome symptoms of menopause not only are varied across specialties but also differ based on how recently physicians were trained and how much knowledge physicians perceive their patients to have about the condition.



Women with hot flashes related to menopause carry the burden of these symptoms, but new research highlights the economic toll if left untreated.

Women taking compounded bioidentical hormones for symptoms of menopause don't know as much as they should about the therapy.

New research shows hot flashes last longer than once thought, and when they begin can indicate how long hot flashes will linger.

Even brief use of hormone replacement therapy in menopause can increase risk of the 2 most common forms of ovarian cancer, a meta-analysis finds.

Women with higher levels of endocrine-disrupting chemicals from both environmental and household exposure have an earlier onset of menopause.

Women who experience menopause before age 46 have an increased risk of heart disease, and smoking status can modifying this risk in older women.

Vaginal estrogens are effective options for managing bothersome symptoms related to genitourinary syndrome of menopause in postmenopausal women.


Subscribe to Menopause on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.